Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Period end update

13 Oct 2011 07:00

RNS Number : 0892Q
e2v technologies PLC
13 October 2011
 



 

13 October 2011

 

e2v technologies plc

 

Period end update

 

e2v technologies plc, the specialist provider of technology solutions for high performance systems, is today providing this period end update for the six months ended 30 September 2011.

 

Current Year trading and outlook

 

Group trading for the first half is expected to be in line with management's expectations and ahead of the comparable period in the previous year. Underlying revenue grew by over 16%, with reported revenue growth of 9%. The difference largely reflects one off revenues of £6m.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan and our outlook for the full year remains unchanged.

 

RF Power Solutions

 

The RF Power Solutions Division has three key applications: radiotherapy, electronic countermeasures and industrial processing.

 

- Strong growth over the comparable period in radiotherapy reflects steady OEM demand.

- As anticipated, European demand for electronic countermeasures (ECM) continues to be lower. We have secured an order for microwave power modules from a European OEM and are also making good progress with two US ECM programmes.

- In industrial processing systems, agreement has been reached for the first commercial field trial installation of our ProWave™ vermiculite processing system, which is due to be installed shortly. We have made good progress on our development programmes and have recently received a further order for an RF generator to support research into a new potential application in the mining sector.

- The remaining product lines in the division, which serve predominantly commercial and industrial markets, continue to perform well relative to the prior year and steadily on a sequential basis.

 

 

 

High Performance Imaging Solutions

 

The three key applications of this division are: machine vision, space imaging and scientific imaging.

 

- The machine vision sector delivered comparable underlying performance with the prior year, although this has shown some recent softness.

- Space imaging has delivered significant growth over the comparable period, reflecting the achievement of milestones on established programmes and progress on new projects. We have received an order for a focal array subsystem for a Korean land based telescope and have been selected to provide the camera for a ground based space science application in Brazil.

- Scientific imaging is also showing good growth arising from stronger end user demand.

- The remaining product lines in the division continue to show good underlying growth.

 

Hi-rel Semiconductor Solutions

 

This division addresses two main sectors: Semiconductor Lifecycle Management (SLiM™) and aerospace and defence semiconductors.

 

- The SLiM™ programme continues to benefit from the successful delivery within its existing programmes and a further four new defence programmes in Europe and the US have been added in the period, as well as the extension of the Raytheon F15 contract to cover further product lines. We also secured our first customer contract to provide extended product availability in collaboration with Maxim Semiconductors Inc.

- For the remaining product lines in the division we have seen improved demand for test and assembly services in Europe and the US compared to the prior year.

 

Order Book

 

Our total order book as at 30 September 2011 was £146m (30 September 2010 £167m), whilst our order book for delivery in the coming 12 months as at 30 September 2011 was £120m (30 September 2010 £147m). The reduction in the order book for delivery in the coming 12 months reflects a £7m reduction in the level of 'one-off' orders and the cycle of multiyear radiotherapy orders of £9m. We are also seeing a change in mix, as European defence activity (reduced by £2m) has been replaced with more commercial and industrial business with shorter order cycles.

 

 

 

Net Borrowings

 

Net borrowings at 30 September 2011 increased from 30 June 2011 by £4m to £32m, with operational cash performance in line with our expectations.

 

The group's new £80m revolving banking facility became effective 27 July 2011 and expires on 27 July 2015. As at 30 September 2011 the group had available £41m of undrawn committed borrowings from the facility.

 

The group remains in a sound financial position.

 

 

 

Keith Attwood, Chief Executive, said:

 

"The group has performed strongly in the first half. The changing order book profile reflects the anticipated change in the mix of our businesses.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan. We are securing early orders for our industrial processing systems business and repositioning ourselves in the value chain for key applications such as space imaging and electronic counter measures.

 

Our outlook for the full year remains unchanged."

 

 

 

Further enquiries:

 

e2v technologies plc

Tel: +44 (0)1245 493 493

Keith Attwood, Chief Executive

Charles Hindson, Group Finance Director

Website: www.e2v.com

Pelham Bell Pottinger

Tel: +44 (0)20 7861 3232

Archie Berens

Clare Gilbey

 

 

Notes to editors

 

 

1. Net borrowings exclude capitalised borrowing costs.

 

2. All financial information included in this release is sourced from management accounts.

 

3. Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect the Group's current expectations concerning future events and actual results may differ materially from current expectations or historical results.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMMMGNZGGMZM
Date   Source Headline
22nd Sep 20112:09 pmRNSHolding(s) in Company
12th Sep 20115:02 pmRNSTotal Voting Rights
8th Aug 20113:52 pmRNSHolding(s) in Company
4th Aug 20117:00 amRNSVermiculite Processing System Field Trial
28th Jul 20117:00 amRNSNew Banking Facilities
27th Jul 20114:28 pmRNSResult of AGM
15th Jul 201110:17 amRNSHolding(s) in Company
8th Jul 201110:47 amRNSStatement Re Boiler Room Scams
8th Jun 20113:46 pmRNSTotal Voting Rights
6th Jun 20114:49 pmRNSFinal Dividend Timetable
6th Jun 20117:00 amRNSFinal Results
27th May 20119:45 amRNSHolding(s) in Company
21st Apr 20111:55 pmRNSTotal Voting Rights
21st Apr 201112:56 pmRNSDirector/PDMR Shareholding
12th Apr 20113:00 pmRNSe2v awarded up to £6.2m development grant
11th Apr 20117:00 amRNSYear end trading update & dividend declaration
4th Mar 201110:30 amRNSHolding(s) in Company
22nd Feb 20113:45 pmRNSHolding(s) in Company
2nd Feb 20112:00 pmRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSInterim Management Statement
28th Jan 20111:30 pmRNSDirectorate Change
20th Jan 20112:30 pmRNSBank arrangements concerning dividends
6th Dec 20104:57 pmRNSTotal Voting Rights
19th Nov 20103:21 pmRNSHolding(s) in Company
18th Nov 201012:12 pmRNSChange of Director's Details
17th Nov 20104:40 pmRNSHolding(s) in Company
15th Nov 20107:00 amRNSHalf Yearly Report
9th Nov 201012:11 pmRNSHolding(s) in Company
28th Oct 20107:00 amRNSAppointment of New Non Executive Director
12th Oct 201012:15 pmRNSHolding(s) in Company
11th Oct 20107:00 amRNSPeriod end update
7th Sep 20107:00 amRNSUpdate on Restructuring
25th Aug 201010:40 amRNSHolding(s) in Company
11th Aug 201011:15 amRNSHolding(s) in Company
4th Aug 20108:45 amRNSAwards under Long Term Incentive Plan
29th Jul 20102:57 pmRNSAGM Statement
26th Jul 20107:00 amRNSStrategy Briefing
23rd Jul 201012:42 pmRNSTotal Voting Rights
19th Jul 20107:00 amRNSInterim Management Statement
14th Jul 201010:15 amRNSHolding(s) in Company
21st Jun 20104:35 pmRNSPrice Monitoring Extension
4th Jun 201011:38 amRNSHolding(s) in Company
17th May 201012:53 pmRNSTotal Voting Rights
10th May 20107:00 amRNSAppointment of corporate broker
7th May 20102:00 pmRNSHolding(s) in Company
4th May 20101:35 pmRNSHolding(s) in Company
29th Apr 20109:19 amRNSAdditional Listing
28th Apr 20103:40 pmRNSHolding(s) in Company
12th Apr 20107:00 amRNS2010 Year End Trading update
7th Apr 20109:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.